News & Updates
Corporate announcements, scientific milestones and latest developments.
Global Launch of LiverAce™ RUO Kits
Read article →Commercial Availability of LiverAce™ RUO Kits
Granada, Spain – December 1, 2025. Destina Genomica is proud to announce the global commercial launch of our LiverAce™ Research Use Only (RUO) kits. These advanced assays are designed to provide pharmaceutical developers and CROs with high-specificity detection of liver injury biomarkers, facilitating more accurate toxicology studies and drug safety assessments.
The LiverAce™ platform leverages our proprietary chemistry to deliver superior sensitivity without the need for amplification, streamlining workflows in pre-clinical settings.
Destina Secures €2.2M CDTI Funding Following EIC Seal of Excellence Award
Read article →Major Milestone: €2M Non-Dilutive Funding Secured
We are proud to announce that CDTI has backed Destina Genomica with €2 Million, validating our EIC Seal of Excellence. This funding accelerates our clinical roadmap and further de-risks our growth trajectory.
Read the full announcements:
→ Official Announcement at CDTI → Local Coverage at Granada Hoy (Español) → Local Coverage at Granada Hoy (English Version)